This document discusses succinylcholine apnea, which is a prolonged paralysis caused by failure to metabolize the muscle relaxant succinylcholine. It is most commonly caused by low or atypical levels of the plasma cholinesterase enzyme. The document notes that atypical plasma cholinesterase is more common in those of Arya Vysya ethnicity from parts of India. It provides guidelines for identifying patients at risk of succinylcholine apnea prior to surgery using blood tests, discusses treatment options, and shares two experiences the author had with patients who experienced prolonged paralysis due to low plasma cholinesterase levels.